Transforming growth factor-β signalling pathway in tendon healing.
Smad
Transforming growth factor-β signalling
fibrosis
tendon injury
Journal
Growth factors (Chur, Switzerland)
ISSN: 1029-2292
Titre abrégé: Growth Factors
Pays: England
ID NLM: 9000468
Informations de publication
Date de publication:
08 2022
08 2022
Historique:
pubmed:
17
6
2022
medline:
17
8
2022
entrez:
16
6
2022
Statut:
ppublish
Résumé
Transforming growth factor-β(TGF-β) plays an important but diverse role in tendon injuries, such as collagen synthesis, cell proliferation, cell differentiation, and cell adhesion, leading to tendon healing and tendon fibrosis. In the well-known canonical TGF-β signalling pathway, TGF-β activates Smad signalling through its two cell surface receptors, which leads to Smad-mediated transcriptional regulation and is also regulated by inhibitory Smads, forming a negative feedback regulatory pathway. In the context of the canonical TGF-β signalling mechanism mediated by Smad, the activated receptors also send signals through other signal transducers, which in the backdrop of TGF-β signaling are collectively known as non-Smad signalling pathways. Activated TGF-β binds to the receptor and acts through these signalling pathways. Understanding the mechanism of the TGF-β signalling pathway and its role in tendon repair is of great significance for targeting the TGF-β signalling pathway to accelerate tendon healing and reduce tendon fibrosis.
Identifiants
pubmed: 35707986
doi: 10.1080/08977194.2022.2082294
doi:
Substances chimiques
Smad Proteins
0
Transforming Growth Factor beta
0
Transforming Growth Factor beta1
0
Transforming Growth Factors
76057-06-2
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM